IVF · Fertilisation technique
ICSI versus conventional IVF — when each is the right choice
Conventional in-vitro fertilisation (IVF) lets the oocyte and sperm meet in a dish; intracytoplasmic sperm injection (ICSI) places a single sperm directly inside each mature oocyte. Both produce embryos. The choice between them is not a matter of preference — it is an evidence-based decision based on sperm quality and prior cycle history. This page explains when each is indicated, when they are not, and how to interpret the choice in your treatment plan.
How they differ
- Conventional IVF — mature oocytes are placed in a dish with prepared sperm at a concentration of approximately 50,000–100,000 motile sperm per oocyte. Fertilisation happens naturally.
- ICSI — under microscope, a single sperm is injected through the zona pellucida into the cytoplasm of each mature oocyte. Used to bypass severe sperm-related fertilisation barriers.
Clear indications for ICSI
- Severe male-factor infertility (low count, low motility, low normal morphology)
- Total fertilisation failure or very low fertilisation in a prior conventional cycle
- Surgically retrieved sperm (PESA, TESA, micro-TESE) — ICSI is mandatory
- Frozen-thawed sperm in selected cases
- Pre-implantation genetic testing (PGT) cycles — to avoid extraneous sperm DNA on the embryo
- Unexplained fertilisation failure in a prior cycle
When ICSI is not indicated
- Normal semen parameters with no prior fertilisation failure
- Routine IVF cycles in patients with isolated tubal or ovulatory factor
- Older maternal age alone (not an indication)
- Unexplained infertility with normal semen (not a clear indication; conventional IVF is preferred)
Defaulting to ICSI in all cycles is a recognised over-use pattern in some clinics. The institutional position here is that ICSI is used when there is an evidence-based indication, not as a routine.
What the evidence shows
For non-male-factor infertility, ICSI does not improve live birth rates over conventional IVF and adds cost and a small additional procedural risk. For male-factor infertility, ICSI substantially improves fertilisation and live birth outcomes. The data are clear in both directions.
IMSI and PICSI
Two ICSI variants exist:
- IMSI (intracytoplasmic morphologically selected sperm injection) — very-high-magnification selection of sperm before injection. Limited evidence for routine clinical benefit; used selectively.
- PICSI (physiological ICSI) — sperm selection on a hyaluronan-coated dish to mimic the natural ZP binding. Mixed evidence; used selectively, particularly in repeat ICSI failure.
Neither is offered as a routine add-on without a specific indication.
Cycle planning
The fertilisation method is decided pre-cycle based on semen analysis and history. In selected cases a “split” cycle is performed — half the oocytes go to conventional IVF, half to ICSI — particularly where prior fertilisation rate was low but not zero. The patient is counselled on the rationale.
When to ask about the choice
- You are scheduled for ICSI but have a normal semen analysis — reasonable to ask why
- Repeated ICSI cycles with low fertilisation — reasonable to ask about IMSI/PICSI or split cycles
- A clinic recommends ICSI for “safety” alone — the evidence does not support this
Guidelines we follow on this topic
- ESHRE good clinical practice on ICSI
- ASRM/ESHRE consensus on ART add-ons
- NICE fertility guidance
Related reading
Dr. Priyadatt Patel
Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead
MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation
ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.
Science City Road, Ahmedabad 380060
Mon–Sat 11:00–20:00 · +91 97234 31544
Naranpura, Ahmedabad
Mon–Sat 08:30–10:30 · +91 70460 02566